Just complete the form below and we’ll be in touch

The stats are startling

Studies have shown that 4 out of 5 AFib and heart failure (HF) patients have sleep apnea (SA).1-3 Untreated SA has serious clinical consequences in cardiac patients,4-7 including:

57%

increased risk of AFib recurrence post-ablation4

2X

higher mortality rate in HF5*

Studies in patients with obstructive SA

Have you run into these hurdles?

If any answers are yes, it’s time to call on WatchPAT® Cardio Sleep Solutions.

WatchPAT® Cardio Sleep Solutions: accelerating sleep apnea care every step of the way

Tailored, best-in-class programs for SA management at all stages of the care pathway—from testing and diagnosis to treatment and monitoring

WatchPAT® On Demand

A customized program for cardiology practices with in-house sleep labs

WatchPAT® TurnKey

Our comprehensive program that does it all for you

An expansive ecosystem with board-certified sleep physicians and select DME partners to ensure the highest quality of care

These complimentary programs are available when you prescribe industry-leading WatchPAT® home sleep apnea tests (HSATs)

Want to know more? Just complete the form below and we’ll be in touch

*In patients with moderate or severe obstructive SA.

†With the WatchPAT® ONE fully disposable HSAT. Complete automated study report posted in the cloud within minutes of test completion.

References: 1. Shapira-Daniels A, Mohanty S, Contreras-Valdes M, et al. Prevalence of undiagnosed sleep apnea in patients with atrial fibrillation and its impact on therapy. J Am Coll Cardiol EP. 2020;6:1499-1506. 2. Paulino A, Damy T, Margarit L, et al. Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis. 2009;102:169-175. 3. Herrscher TE, Akre H, Overland B, et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Cardiac Fail. 2011;17:420-425. 4. Li L, Wang Z-w, Li J, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014;16:1309-1314. 5. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-1631. 6. Damy T, Margarit L, Noroc A, et al. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail. 2012;14:1009-1019. 7. Jilek C, Krenn M, Sebah D, et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail. 2011;13:68-75. 8. Yalamanchali S, Farajian V, Hamilton, C, et al. Diagnosis of obstructive sleep apnea by peripheral arterial tonometry: meta-analysis. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1343-1350. 9. Tanaka N, Tanaka K, Hirao Y, et al. Home sleep apnea test to screen patients with atrial fibrillation for sleep apnea prior to catheter ablation. Circ J. 2021;85:252-260.

Copyright © 2022 Itamar Medical Ltd. All rights reserved. WatchPAT and PAT are trademarks or registered trademarks of Itamar Medical Ltd., a subsidiary of ZOLL Medical Corporation, in the United States and/or other countries. All other trademarks are the property of their respective owners.